Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
Public ClinicalTrials.gov record NCT00668850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-Week, Open-Label, Randomized, Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin In Subjects With Type-1 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the efficacy of Generex Oral-lyn™ RapidMist™ System and standard regular human insulin therapy as measured by HbA1c, in type-1 diabetes mellitus subjects on BID NPH intermediate acting insulin therapy.
Study identification
- NCT ID
- NCT00668850
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Aug 2011 (Estimated)
- Completion
- Sep 2011 (Estimated)
- Last update posted
- Jun 8, 2011
2008 – 2011
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Biomedical Research Inc. at Santa Monica | 2001 Santa Monica Blvd Suite 390W | California | 90404 | — |
| The Center for Diabetes & Endocrine Care at Hollywood | 1150 N. 35th Ave Suite 590 | Florida | 33021 | — |
| Physicians Research Group at Indianapolis | 7400 North Shadeland Ave | Indiana | — | — |
| MODEL Clinical Research at Baltimore | 6535 North Charles Street Suite 400N | Maryland | 21204 | — |
| Grunberger Diabetes Institute at Bloomfield Hills | 43494 Woodward Ave Suite 208 | Michigan | 48302 | — |
| Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York | 317 East 17th Street Room 7F05 8th Floor | New York | 10003 | — |
| Multiple Health Research, LLC. at Arlington | 501 Rita Lane Suite 113 | Texas | 76014 | — |
| University of Texas Southwestern Medical Center at Dallas | 5323 Harry Hines Blvd | Texas | 75390-8858 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00668850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2011 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00668850 live on ClinicalTrials.gov.